Cronos Australia
Cronos Australia is committed to providing Australian patients access to the highest quality medicinal cannabis products, as well as supplying export markets globally. Our vision is to become a leading health and wellness company in the Asia Pacific region with a portfolio of cannabinoid products – including THC and CBD.
Our business model is underpinned by innovative product and brand development, outsourced manufacturing and distribution for Australia and target export markets.
Three Pillars
Cronos Australia’s operations are based on Pillars;
Our medicinal cannabis products including premium quality, value priced, GMP certified medicinal cannabis oils.
Our Cannadoc Medicinal Cannabis Clinic business located in Melbourne, Australia and Wellington, New Zealand. The clinics conduct patient consultations face-to-face and nationwide via telehealth.
Our Asia consumer business, with the in-market BATHING SHED brand with two additional consumer brands being launched in 2021 for the lucrative North Asia markets including Hong Kong and Japan.
CBD Joint Venture – An innovative joint venture with the Founders of Sukin Natural Skincare for the Australian over-the-counter CBD market and target export markets.
Cronos Australia is listed on the ASX, under the code CAU.
Director
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Director
Guy R. Headley
Guy Headley was appointed Executive Director and Chief Commercial Officer of Cronos Australia on 16 December 2021. Guy has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director of the Emerging Therapeutics Association of Australia.
Director
Dr. Benjamin D.N. Jansen
Qualifications: FRACGP, FRNZCUCP, FRNZCGP, MBChB, BHB, PGDipSpMed, PGDipCEM
Dr. Ben Jansen was appointed Executive Director and Chief Medical Officer of Cronos Australia on 16 December 2021. As a founding Director of CDA Health Pty. Ltd. and Cannabis Doctors Australia Pty. Ltd., Ben has played a key role in advancing and advocating access and education for medicinal cannabis patients within Australia and New Zealand. Ben is arguably Australia’s most experienced medicinal cannabis clinician, having been directly involved with the treatment of thousands of patients. He is a Fellow of the Royal Australian and Royal New Zealand College of General Practitioners and a Fellow of the Royal New Zealand College of Urgent Care Physicians. Ben received a Bachelors degree of Medicine, a Bachelors degree of Surgery, a Bachelors degree of Human Biology, and a Post Graduate Diploma in Community Emergency Medicine from the University of Auckland. He also received a Post Graduate Diploma in Sports Medicine from the University of Otago in New Zealand.
Director
Dr. Marcia A.M. Walker
Qualifications: BHB, MBChB, FRNZCGP
Other responsibilities: Chair of Audit and Risk Committee, Member of Nomination and Remuneration Committee
Dr. Marcia Walker was appointed Non-Executive Director of Cronos Australia on 16 December 2021. Marcia brings significant experience in Medical Governance and currently serves on the board of the New Zealand Medical Association, is a member of the General Practitioner Council of the NZMA, a member of the Medicines Classifications Committee for the Ministry of Health NZ and acts as a Medical Examiner for the Royal New Zealand College of General Practitioners. Previously, she acted as a Medical Advisor to the Rua BioScience (formerly Hikurangi Hemp Company) and Treasurer for the New Zealand Resident Doctors Association. Marcia received a Bachelor of Medicine and a Bachelor of Surgery / Chirurgery from the University of Auckland and is a fellow of the Royal New Zealand College of General Practitioners. She also acts as the Medical Director of The Cosmetic Clinic New Zealand.
Management
Management
Rodney D. Cocks CSM
Qualifications: BCom (Melb.), LLB (QUT), MBA (Wharton), MPA (Harvard), GAICD
Rodney Cocks CSM was appointed Executive Director and Chief Executive Officer of Cronos Australia on 27 September 2018. He is a Director of NewSouthern Capital Pty. Ltd., a private equity firm he co-founded. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army. Rodney holds a BCom from the University of Melbourne, LLB from the Queensland University of Technology, MBA from the Wharton School, University of Pennsylvania, MPA from the Harvard Kennedy School, Harvard University and is a Graduate of the Australian Institute of Company Directors and the Royal Military College, Duntroon. He is an admitted Lawyer to the Supreme Court of New South Wales, was a Fellow at Harvard University and named the 2005 Victorian Australian of the Year. In 2003, Rodney was awarded a Conspicuous Service Medal for his actions in the aftermath of the 2002 Bali bombings.
Management
Thomas G. Howitt
Qualifications: BCom (University of Western Australia), CA, AICPA, AGIA, ACIS, CTA
Thomas Howitt was appointed as the Chief Financial Officer of CAL on 3 December 2018 and as Company Secretary on 14 August 2020. Prior to joining the Company, he was the Chief Financial Officer of Global Kinetics Corporation, a pre-IPO life sciences company, Chief Financial Officer/ Company Secretary of Simavita (ASX:SVA, TSX-V:SV) a digital healthcare company, Chief Financial Officer/Company Secretary of Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE) a genetic testing company, and several other listed life science companies. Prior to that, Thomas worked in the investment banking industry and was a Taxation Manager at EY. Thomas is a member of the Victorian Branch Committee of AusBiotech and a member of the CCRM Australia Industry Interface Committee based at Monash University
Management
Guy R. Headley
Guy Headley was appointed Executive Director and Chief Commercial Officer of Cronos Australia on 16 December 2021. Guy has operated in the Australian Medical Cannabis space since 2016. He is a founding director of CDA Health Pty. Ltd. and has acted as a director of Burleigh Heads Cannabis Pty. Ltd. over the last five years. He brings a wealth of knowledge regarding medicinal cannabis sales, distribution and compliance in the heavily regulated industry. Prior to working in the cannabis space, Guy spent more than 15 years in the construction and development sector overseeing the procurement and management of multimillion dollar projects across New Zealand, Australia and the United Kingdom. Guy is also a founding Director of the Emerging Therapeutics Association of Australia.
Management
Dr. Benjamin D.N. Jansen
Qualifications: FRACGP, FRNZCUCP, FRNZCGP, MBChB, BHB, PGDipSpMed, PGDipCEM
Dr. Ben Jansen was appointed Executive Director and Chief Medical Officer of Cronos Australia on 16 December 2021. As a founding Director of CDA Health Pty. Ltd. and Cannabis Doctors Australia Pty. Ltd., Ben has played a key role in advancing and advocating access and education for medicinal cannabis patients within Australia and New Zealand. Ben is arguably Australia’s most experienced medicinal cannabis clinician, having been directly involved with the treatment of thousands of patients. He is a Fellow of the Royal Australian and Royal New Zealand College of General Practitioners and a Fellow of the Royal New Zealand College of Urgent Care Physicians. Ben received a Bachelors degree of Medicine, a Bachelors degree of Surgery, a Bachelors degree of Human Biology, and a Post Graduate Diploma in Community Emergency Medicine from the University of Auckland. He also received a Post Graduate Diploma in Sports Medicine from the University of Otago in New Zealand.
Management
Nicholas G. Mulcahy
Qualifications: MA LLB (Hons.)
Prior to joining Cronos Australia in 2019, Nick Mulcahy advised leading direct-to-consumer brands and private equity firms. He lives in Hong Kong and started his career at law firms in Sydney, working in London and across Asia. From 2006 to 2014, he was the head of Asia Pacific at Aesop, building it into a highly respected and coveted brand across Japan, Korea, Hong Kong, Taiwan, Singapore, Malaysia and Australia. Nick holds degrees in Arts and Law from the University of Sydney and a postgraduate degree in Arts from the University of New South Wales. He studied competitive strategy at Harvard Business School.
Founding Member
